The IPO for SK Pharm TECO has been delayed until 2024.

On Wednesday, key officials from the firm and SK affiliates indicated that owing to market volatility, the IPO of SK pharm TECO, a California-based contract research and manufacturing organization under Korean conglomerate SK Inc., will be delayed at least until 2024. CEO of SK pharm TECO Joerg A...

SK HOLDINGS SUBSIDIARY COMPANIES ARE GAINING WELL IN STOCK MARKET

Highlights –

• SK Holdings saw share price gain by nearly 3 percent.
• The gains happened so because of its biotech subsidiary company.
•  SK Pharmteco will provide Virginia-based Phlow with active pharmaceutical ingredients.

GSK PLANS $250 MILLION EQUITY INVESTMENT IN VIR BIOTECHNOLOGY

Highlights

• GSK and Vir Biotechnology will focus on making drugs and vaccines against COVID-19

• Vir Biotechnology will continue it’s partnership with other companies

• Shares of Vir Biotechnology rose by 30 percent on the Nasdaq

Pharm...